Top-News
Werbung
Attraktive Knock-Outs auf Dexcom Inc
Typ Hebel Bid / Ask WKN
Call
4,4 1,29 € / 1,30 €
FD35U9
Typ Hebel Bid / Ask WKN
Put
6,0 0,94 € / 0,95 €
FD1ELH
Den Basisprospekt sowie endgültige Bedingungen und Basisinformationsblätter erhalten Sie bei Klick auf das Dokument-Icon. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Alle Knock-Outs auf Dexcom Inc

Dexcom Aktie News

Aktie
WKN:  A0D9T1 ISIN:  US2521311074 US-Symbol:  DXCM Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
65,86 $
+0,61 $
+0,93%
56,569 € 20:46:09 Uhr
Depot/Watchlist
Marktkapitalisierung *
19,59 Mrd. €
Streubesitz
2,74%
KGV
54,77
neu: Nachhaltigkeits-Score
51 %
Index-Zuordnung
Nasdaq 100
Weiter aufwärts? Long handeln - Jetzt mit Hebel 25,24: VH98JV
Werbung

Dexcom News

20.11.25 - Businesswire
Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the ...
20.11.25 - PR Newswire
The Gross Law Firm Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 26, 2025 - DXCM
The Gross Law Firm Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 26, 2025 - DXCM PR Newswire
20.11.25 - PR Newswire
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit PR Newswire
19.11.25 - Businesswire
Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes
DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the FDA has cleared Dexcom Smart Basal, the first and only CGM-​integrated basal ...
18.11.25 - PR Newswire
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
17.11.25 - PR Newswire
DXCM Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc. (DXCM)
DXCM Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc. (DXCM) PR Newswire
17.11.25 - PR Newswire
Shareholders that lost money on DexCom, Inc. (DXCM) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
Shareholders that lost money on DexCom, Inc. (DXCM) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire
14.11.25 - PR Newswire
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit PR Newswire
14.11.25 - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM PR Newswire
14.11.25 - PR Newswire
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
12.11.25 - PR Newswire
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP PR Newswire
11.11.25 - PR Newswire
Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately
Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately PR Newswire
11.11.25 - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM PR Newswire
11.11.25 - PR Newswire
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
10.11.25 - PR Newswire
DexCom, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 26, 2025 to Discuss Your Rights - DXCM
DexCom, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 26, 2025 to Discuss Your Rights - DXCM PR Newswire
10.11.25 - PR Newswire
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit PR Newswire
07.11.25 - PR Newswire
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM PR Newswire
07.11.25 - PR Newswire
DXCM Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges DXCM Investors with Losses to Contact the Firm
DXCM Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges DXCM Investors with Losses to Contact the Firm PR Newswire
07.11.25 - PR Newswire
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
07.11.25 - Businesswire
Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)
Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Québec government for its recent decision to expand coverage of Dexcom Continuous Glucose ...

Newssuche

Videos

newspaper
10:20 Uhr +1,03%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »